by Jessica Casebolt | Jun 21, 2024 | Payers, Tea Leaves
The issue of high prescription drug costs in America extends beyond the commonly blamed entities like drug companies and insurers. Pharmacy Benefit Managers (PBMs), often overlooked but immensely influential, play a pivotal role. These middlemen, controlled by giants...
by Jessica Casebolt | Jun 21, 2024 | Opioid/Substance Use Disorders, Tea Leaves
Members of the House from both parties have formed a new coalition aimed at addressing China’s involvement in the U.S. fentanyl epidemic. Led by Representatives Dan Newhouse and Jake Auchincloss, the group plans to intensify efforts to curb the supply of this...
by Jessica Casebolt | Jun 21, 2024 | Inequities and SDOH, Tea Leaves
Over the past nine weeks, an exploration into key health care topics has underscored a pervasive theme of inequality that is deeply rooted in America’s health care system, with indications that these disparities may worsen. Access to health care remains unequal...
by Jessica Casebolt | Jun 21, 2024 | Providers, Tea Leaves
Health care providers are grappling with unprecedentedly high labor costs amid ongoing challenges that show no signs of abating. To cope, hospitals and health systems are resorting to innovative strategies such as hefty investments in talent acquisition and retention,...
by Jessica Casebolt | Jun 21, 2024 | Payers, Tea Leaves
Republicans on the House Energy and Commerce Committee sharply criticized the Center for Medicare and Medicaid Innovation (CMMI) during a recent hearing on value-based care, accusing it of failing to achieve cost savings since its inception in 2010. They proposed...
by Jessica Casebolt | Jun 21, 2024 | Opioid/Substance Use Disorders, Tea Leaves
A recent federal study revealed that only 4.1 percent of traditional Medicare enrollees who survived a nonfatal drug overdose in 2020 received effective medications for opioid use disorder within the following year, such as methadone or buprenorphine. This finding...
Recent Comments